Invega 3 mg (Paliperidone TABLET (EXTENDED-RELEASE)) 3 MG

INVEGA 3 MG is an extended-release tablet containing palperidone, used to manage certain mental health conditions. This medication is designed for oral administration and is manufactured by Janssen Inc. in Canada.

Strength

3 MG

Pack Size

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

INVEGA 3 MG is primarily used in the management of schizophrenia and other mental health conditions. Palperidone, the active ingredient, works to help maintain stability in individuals who have been previously treated with this medication. It is often prescribed to support ongoing treatment plans as determined by healthcare providers.

Side Effects

Common effects of INVEGA 3 MG may include drowsiness, dizziness, and weight gain. Some individuals might experience restlessness or tremors. These effects can vary widely among users, and it's important to monitor any changes in physical or mental state while taking this medication.

Precautions & Warnings

INVEGA 3 MG should be handled with care, especially by individuals with a history of heart problems, seizures, or diabetes. It is important to follow the guidance of a healthcare provider regarding the use of this medication. Always store the tablets in a cool, dry place away from children and pets.

Avoid Interactions

INVEGA 3 MG may interact with other medications, including those that affect the central nervous system, such as antidepressants or other antipsychotics. Alcohol and certain supplements can also influence the effects of palperidone. It's advisable to discuss all current medications with a healthcare provider before starting INVEGA 3 MG.

Frequently Asked Questions

INVEGA 3 MG is used to manage schizophrenia and other mental health conditions. It is designed to help maintain stability in individuals who have been previously treated with palperidone.

INVEGA 3 MG is an extended-release tablet meant for oral administration. It should be taken exactly as prescribed by a healthcare provider.

Common side effects may include drowsiness, dizziness, weight gain, and restlessness. Individual experiences can vary.

INVEGA 3 MG may interact with other medications, especially those affecting the central nervous system. Always consult a healthcare provider before combining medications.

INVEGA 3 MG is manufactured by Janssen Inc. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.